07.09.2010
- Glaxosmithkline will not step in as a rival bidder for U.S. biotech Genzyme and take on Sanofi-Aventis, the British drugmaker's head of research and development told a French...
06.09.2010
- French drugmaker Sanofi-Aventis would be prepared to moderately raise its $69 per share offer for Genzyme if the U.S. biotech agreed to negotiate, Dow Jones reported, citing a...
02.09.2010
- U.S. biotech Genzyme, which has rejected an $18.5 billion offer from French drugmaker Sanofi-Aventis, appears to hold the upper hand in the takeover struggle, according to Geoffrey...
02.09.2010
- French oil company Total has received offers for its UK Lindsey refinery and hopes to sell it by the end of the year, Chief Executive Officer Christophe de Margerie, said on...
31.08.2010
- U.S. biotech company Genzyme rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis on Monday, setting the stage for a protracted and potentially hostile...
31.08.2010
- Genzyme rejected an $18.5 billion takeover offer from French drugmaker Sanofi-Aventis, saying it dramatically undervalues the company. The Cambridge, Massachusetts-based...
30.08.2010
- France's Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme in a bid to rouse shareholders after failing to engage the U.S...
26.08.2010
- Sanofi-Aventis shareholders L'oreal and Total worry that the French drugmaker will pay too much for U.S. biotech company Genzyme and are not convinced it is the best fit, bankers...
26.08.2010
- Sanofi-Aventis is not willing to pay more than $70 per share for U.S. biotech Genzyme and may look at alternative targets, Bloomberg reported on Wednesday, citing sources familiar...
24.08.2010
- U.S. biotechnology firm Genzyme and its French suitor Sanofi-Aventis are at odds over the threshold price at which Sanofi could begin the due diligence on Genzyme's books, the Wall...